Publications 2005

Publications of the year [1991] [1992] [1993] [1994] [1995] [1996] [1997] [1998] [1999] [2000] [2001] [2002] [2003] [2004] [2005] [2006] [all]

Carralot, J.P., C. Dumrese, R. Wessel, R. Riessen, I. Autenrieth, S. Walter, O. Schoor, S. Stevanovic, H.-G. Rammensee, S. Pascolo. 2005. CD8⁺ T cells specific for a potential HLA-A*0201 epitope from Chlamydophila pneumoniae are present in the PBMCs from infected patients. Int. Inmunol. 17:591-597.

Carralot, J.P., B. Weide, O. Schoor, J. Probst, B. Scheel, R. Teufel, I. Hörr, C. Garbe, H-G. Rammensee, S. Pascolo. 2005. Production and characterization of amplified tumor-derived cRNA libraries to be used as vaccines against metastatic melanomas. Genet. Vaccines Ther. 3:6.

Decker, P., H. Singh-Jasuja, S. Haager, I. Kotter, H.-G. Rammensee. 2005. Nucleosome, the main autoantigen in systemic lupus erythematosus, induces direct dendritic cell activation via a MyD88-independent pathway: consequences on inflammation. J. Immunol. 174:3326-3334.

Dengjel, J., H.-G. Rammensee, S. Stevanovic. 2005. Glycan side chains on naturally presented MHC class II ligands. J. Mass Spectrom. 40:100-104.

Dengjel, J., O. Schoor, R. Fischer, M. Reich, M. Kraus, M. Müller, K. Kreymborg, F. Altenberend, J. Brandenburg, H. Kalbacher, R. Brock, C. Driessen, H.-G. Rammensee, S. Stevanovic. 2005. Autophagy promotes MHC class II presentation of peptides form intracellular source proteins. Proc. Natl. Acad. Sci. USA 102:7922-7927.

Dittmann, J., K. Keller-Matschke, T. Weinschenk, T. Kratt, T. Heck, H.-D. Becker, S. Stevanovic, H.-G. Rammensee, C. Gouttefangeas. 2005. CD8⁺ T-cell response against MUC-1-derived peptides in gastrointestinal cancer survivors. Cancer Immunol., Immunother. 54:750-758.

Grosse-Hovest, L., W. Wick, R. Minoia, M. Weller, M, H.-G. Rammensee, G. Brem, G. Jung. 2005. Supraagonistic, bispecific single-chain antibody purified from the serum of cloned, transgenic cows induces T-cell mediated killing of glioblastoma cells in vitro and in vivo. Int. J. Cancer 117:1060-1064.

Herter, S., P. Osterloh, N. Hilf, G. Rechtsteiner, J. Hohfeld, H.-G. Rammensee, H. Schild. 2005. Dendritic cell aggresome-like-induced structure formation and delayed antigen presentation coincide in influenza virus-infected dendritic cells. J. Immunol. 175:891-898.

Kramer, B.F., O. Schoor, T. Kruger, C. Reichle, M. Muller, T. Weinschenk, J. Hennenlotter, A. Stenzl, H.-G. Rammensee, S. Stevanovic. 2005. mAGED4-expression in renal cell carcinoma and identification of an HLA-A*25-restricted MHC class I ligand from solid tumor tissue. Cancer Biol. Ther. 4:943-948.

Krüger, T., O. Schoor, C. Lemmel, B. Krämer, C. Reichle, J. Dengjel, T. Weinschenk, M. Müller, J. Hennenlotter, A. Stenzl, H.-G. Rammensee, S. Stevanovic. 2005. Lessons to be learned from primary renal cell carcinomas: novel tumor antigens and HLA ligands for immunotherapy. Cancer Immunol., Immunother. 54:826-836.

Nastke, M.-D., L. Herrgen, S. Walter, D. Wernet, H.-G. Rammensee, S. Stevanovic. 2005. Major contribution of codominant CD8 and CD4 T cell epitopes to the human cytomegalovirus-specific T cell repertoire. Cell. Mol. Life Sci. 62:77-86.

Neumeister, B., M. Faigle, D. Spitznagel, A. Mainka, A. Ograbek, H. Wieland, N. Mannowetz, H.-G. Rammensee. 2005. Legionella pneumophila down-regulates MHC class I expression of human monocytic host cells and thereby inhibits T cell activation. Cell. Mol. Life Sci. 62:578-588.

Pascolo, S., F. Ginhoux, N. Laham, S. Walter, O. Schoor, J. Probst, P. Rohrlich, F. Obermayr, P. Fisch, O. Danos, R. Ehrlich, F.A. Lemonnier, H.-G. Rammensee. 2005. The non-classical HLA class I molecule HFE does not influence the NK-like activity contained in fresh human PBMCs and does not interact with NK cells. Int. Immunol.17:117-122.

Ramirez, S.R., J. Singh-Jasuja, T. Warger, S. Braedel-Ruoff, N. Hilf, K. Wiemann, H.G. Rammensee, H. Schild. Glycoprotein 96-actiated dendritic cells induce a CD8-biased T-cell response. 2005. Cell Stress Chaperones 10:221-229.

Scheel, B., R. Teufel, J. Probst, J.-P. Carralot, J. Geginat, M. Radsak, D. Jarrossay, H. Wagner, G. Jung, H.-G. Rammensee, I. Hörr, S. Pascolo. 2005. Toll-like receptor-dependent activation of several human blood cell types by protamine-condensed mRNA. Eur. J. Immunol. 35:1557-1566.

Schilbach, K., G. Kerst, S. Walter, M. Eyrich, D. Wernet, R. Handgretinger, W. Xie, H.-G. Rammensee, I. Müller, H.-J. Bühring, D. Niethammer. 2005. Cytotoxic minor histocompatibility antigen HA-1-specific CD8⁺ effector memory T cells: Artificial APCs pave the way for clinical application by potent primary in vitro induction. Blood 106:144-149.

Schuler, M.M., P. Donnes, M.D. Nastke, O. Kohlbacher, H.-G. Rammensee, S. Stevanovic. 2005. SNEP: SNP-derived epitope prediction program for minor H antigens. Immunogenetics 57:816-820.

Tammiruusu, A., A. Haveri, S. Pascolo, R. Lahesmaa, S. Stevanovic, H.-G. Rammensee, M. Sarvas, M. Puolakkainen, J.M. Vuola. 2005. Clearance of Chlamydia pneumoniae infection in H-2 class I human leucocyte antigen-A2.1 monochain transgenic mice. Scand. J. Immunol. 62:131-139.

Tenzer, S., B. Peters, S. Bulik, O. Schoor, C. Lemmel, M.M. Schatz, P.M. Kloetzel, H.-G. Rammensee, H. Schild, H.G. Holzhutter. 2005. Modeling the MHC class I pathway by combining predictions of proteasomal cleavage, TAP transport and MHC class I binding. Cell Mol. Life Sci. 62:1025-1037.

Teufel, R., J.-P. Carralot, B. Scheel, J. Probst, S. Walter, G. Jung, I. Hörr, H.-G. Rammensee, S. Pascolo. 2005. Human peripheral blood mononuclear cells transfected with messenger RNA stimulate antigen-specific cytotoxic T lymphocytes in vitro. Cell Mol. Life Sci. 62:1755-1762.

Walter, S., G. Bioley, H.J. Bühring, S. Koch, D. Wernet, A. Zippelius, G. Pawelec, P. Romero, S. Stevanovic, H.-G. Rammensee. 2005. High frequencies of functionally impaired cytokeratin 18-specific CD8⁺ T cells in healthy HLA-A2+ donors. Eur. J. Immunol. 35:2876-2885.

Wiemann, K., H.W. Mittrucker, U. Feger, S.A. Welte, W.M. Yokoyama, T. Spies, H.-G. Rammensee, A. Steinle. 2005. Systemic NKG2D down-regulation impairs NK and CD8 T cell responses in vivo. J. Immunol. 175:720-729.